Ray Dalio Bristol Myers Squibb CO Transaction History
Bridgewater Associates, LP
- $20.7 Billion
- Q1 2025
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bridgewater Associates, LP holds 2,341,238 shares of BMY stock, worth $105 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
2,341,238
Previous 2,061,076
13.59%
Holding current value
$105 Million
Previous $117 Million
22.49%
% of portfolio
0.69%
Previous 0.55%
Shares
26 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.58 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.11 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.84 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.25 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$2.98 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $95.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...